BRSK1 Antibodies

Santa Cruz Biotechnology provides a broad selection of BRSK1 monoclonal antibodies for research focused on understanding BRSK1 protein functions. BRSK1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BRSK1, or Brain-specific kinase 1, is a serine/threonine kinase that plays a crucial role in neuronal development and function. BRSK1 actively participates in cell cycle regulation and has significant implications in various neurological disorders. Research has shown that BRSK1 expression patterns vary across different neural tissues and developmental stages. Understanding BRSK1's molecular mechanisms and signaling pathways can provide valuable insights into potential therapeutic strategies for neurodegenerative diseases. Ongoing studies continue to reveal new aspects of BRSK1's involvement in cellular processes and disease progression. Current research indicates that BRSK1 may serve as a promising therapeutic target for various neurological conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of BRSK1's role in health and disease.